Synovial sarcoma
|
15
|
10 (67%)
|
0.027
|
12 (80%)
|
< 0.001
|
8 (53%)
|
0.010
|
8 (53%)
|
0.077
|
Leiomyosarcoma
|
13
|
8 (62%)
| |
8 (62%)
| |
10 (77%)
| |
8 (62%)
| |
Undifferentiated sarcoma
|
10
|
8 (80%)
| |
9 (90%)
| |
7 (70%)
| |
7 (70%)
| |
Liposarcoma, myxoid
|
9
|
0 (0%)
| |
0 (0%)
| |
0 (0%)
| |
1 (11%)
| |
Liposarcoma, WD
|
4
|
1 (25%)
| |
1 (25%)
| |
1 (25%)
| |
0 (0%)
| |
Liposarcoma, dedifferentiated
|
3
|
0 (0%)
| |
0 (0%)
| |
1 (33%)
| |
1 (33%)
| |
Rhabdomyosarcoma, alveolar
|
3
|
1 (33%)
| |
3 (100%)
| |
1 (33%)
| |
1 (33%)
| |
Rhabdomyosarcoma, embryonal
|
2
|
1 (50%)
| |
2 (100%)
| |
0 (0%)
| |
0 (0%)
| |
Rhabdomyosarcoma, pleomorphic
|
1
|
0 (0%)
| |
1 (100%)
| |
0 (0%)
| |
0 (0%)
| |
Rhabdomyosarcoma, spindle
|
1
|
1 (100%)
| |
1 (100%)
| |
1 (100%)
| |
1 (100%)
| |
Myxofibrosarcoma
|
6
|
4 (67%)
| |
3 (50%)
| |
2 (33%)
| |
2 (33%)
| |
MPNST
|
5
|
2 (40%)
| |
1 (20%)
| |
3 (60%)
| |
1 (20%)
| |
Epithelioid sarcoma
|
4
|
3 (75%)
| |
3 (75%)
| |
4 (100%)
| |
4 (100%)
| |
Ewing sarcoma
|
4
|
3 (75%)
| |
3 (75%)
| |
3 (75%)
| |
2 (50%)
| |
Fibrosarcomaa
|
4
|
2 (50%)
| |
4 (100%)
| |
1 (25%)
| |
2 (50%)
| |
Angiosarcoma
|
3
|
3 (100%)
| |
3 (100%)
| |
3 (100%)
| |
2 (67%)
| |
Low-grade myofibroblastic sarcoma
|
2
|
2 (100%)
| |
2 (100%)
| |
0 (0%)
| |
0 (0%)
| |